DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study


Iglicki M., Busch C., Zur D., Okada M., Mariussi M., Chhablani J. K., ...Daha Fazla

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, cilt.39, sa.1, ss.44-51, 2019 (SCI-Expanded) identifier identifier identifier

Özet

Purpose: To investigate efficacy and safety of repeated dexamethasone (DEX) implants over 24 months, in diabetic macular edema (DME) eyes that were treatment naive compared with eyes refractory to anti-vascular endothelial growth factor treatment, in a real-life environment.